Lates News

According to the AI bulletin of Every Economic, Huatai Securities released a research report on April 30, giving a buy rating to KSC Bio (688046.SH). The reasons for the rating mainly include: 1) domestic new production capacity is close to full production, continuously optimizing the shipping system to reduce costs; 2) rapid growth of overseas business, increasing market expansion in overseas markets; 3) maintaining high-intensity investment in research and development, enriching the category of experimental animal models. (Daily Economic News)